{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T12:14:38Z","timestamp":1776687278316,"version":"3.51.2"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009122","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2022R1A2C1003624"],"award-info":[{"award-number":["NRF-2022R1A2C1003624"]}],"id":[{"id":"10.13039\/100009122","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cerebral palsy (CP), primarily caused by perinatal cerebral hypoxia and ischemia, is a devastating neurological disease in children characterized by motor, behavioral, and cognitive disorders. This study aimed to evaluate the therapeutic effects of amniotic membrane mesenchymal stem cell-derived exosome-rich conditioned medium (ERCM) in a CP model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>ERCM components were analyzed using enzyme-linked immunosorbent assay. Biodistribution was examined via fluorescence-labeled ERCM in both normal and CP induced animals. In vitro, the neuroprotective effects of ERCM against lipopolysaccharide and potassium cyanide-induced cytotoxicity were assessed in human neural stem cells and oligodendrocyte progenitor cells, focusing on apoptosis, inflammation, and oligodendrocyte differentiation. In vivo, ERCM was injected into CP-induced animals, followed by evaluation of antiapoptotic and anti-inflammatory signaling, motor and cognitive function, and white matter integrity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>ERCM contained a broad array of growth factors and demonstrated enhanced retention in CP-affected brain regions. In vitro, ERCM significantly reduced apoptos is and inflammation, and promoted oligodendrocyte maturation via upregulation of Nkx2.2, CN Pase, and MBP. In vivo, ERCM treatment improved motor and cognitive performance, in hibited cell death and inflammatory responses, and increased expression of oligodendrocyte markers, including Nkx2.2, Olig2, CNPase, and MBP via increasing growth factor expression. Furthermore, ERCM attenuated demyelination in the corpus callosum, a region particularly vulnerable in CP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ERCM confers therapeutic benefits in CP by preserving neural stem and oligodendrocyte progenitor cells, modulating apoptosis and inflammation, and enhancing oligodendrocyte differentiation. Accordingly, ERCM may present a good candidate as a CP therapeutic agent.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/stcltm\/szaf071","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:03:59Z","timestamp":1764248639000},"source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic effect of amniotic membrane mesenchymal stem cell-derived exosome-rich conditioned medium in cerebral palsy model"],"prefix":"10.1093","volume":"15","author":[{"given":"Eun-Jung","family":"Yoon","sequence":"first","affiliation":[{"name":"Laboratory of Veterinary Toxicology, College of Veterinary Medicine, Kangwon National University , Chuncheon-si 24341,","place":["Republic of Korea"]},{"name":"Department of Life Sports Educator, Kongju National University , Kongju 32588,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwon","family":"Jeong","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Toxicology, College of Veterinary Medicine, Kangwon National University , Chuncheon-si 24341,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunseo","family":"Choi","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Toxicology, College of Veterinary Medicine, Kangwon National University , Chuncheon-si 24341,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Hwan","family":"Kim","sequence":"additional","affiliation":[{"name":"Platform Technology Group, Prestige Biopharma IDC , Busan 46726,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Myoung","family":"Kim","sequence":"additional","affiliation":[{"name":"Central Research Institute, Designed Cells Co., Ltd , Cheongju 28576,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehn-Kyoung","family":"Choi","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Toxicology, College of Veterinary Medicine, Chungbuk National University , Cheongju-si 28644,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Bae","family":"Kim","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Toxicology, College of Veterinary Medicine, Chungbuk National University , Cheongju-si 28644,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6042-5949","authenticated-orcid":false,"given":"Dongsun","family":"Park","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Toxicology, College of Veterinary Medicine, Kangwon National University , Chuncheon-si 24341,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"2026010905594828200_szaf071-B1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/mrdd.10007","article-title":"Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults","volume":"8","author":"Hagberg","year":"2002","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"2026010905594828200_szaf071-B2","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1177\/0963689718781330","article-title":"Improvement by human oligodendrocyte progenitor cells of neurobehavioral disorders in an experimental model of neonatal periventricular leukomalacia","volume":"27","author":"Kim","year":"2018","journal-title":"Cell Transplant"},{"key":"2026010905594828200_szaf071-B3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1474-4422(08)70294-1","article-title":"Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances","volume":"8","author":"Volpe","year":"2009","journal-title":"Lancet Neurol"},{"key":"2026010905594828200_szaf071-B4","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1001\/archneur.65.10.1291","article-title":"Progress in periventricular leukomalacia","volume":"65","author":"Deng","year":"2008","journal-title":"Arch Neurol"},{"key":"2026010905594828200_szaf071-B5","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1542\/peds.2004-0221","article-title":"Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s","volume":"115","author":"Wilson-Costello","year":"2005","journal-title":"Pediatrics"},{"key":"2026010905594828200_szaf071-B6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1523\/JNEUROSCI.22-02-00455.2002","article-title":"Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia","volume":"22","author":"Back","year":"2002","journal-title":"J Neurosci"},{"key":"2026010905594828200_szaf071-B7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1055\/s-2008-1041104","article-title":"Hypoxic-ischemic brain injury in the newborn","volume":"13","author":"Rivkin","year":"1993","journal-title":"Semin Neurol"},{"key":"2026010905594828200_szaf071-B8","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/01.STR.0000254729.27386.05","article-title":"Maturation-dependent vulnerability of perinatal white matter in premature birth","volume":"38","author":"Back","year":"2007","journal-title":"Stroke"},{"key":"2026010905594828200_szaf071-B9","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1523\/JNEUROSCI.21-04-01302.2001","article-title":"Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury","volume":"21","author":"Back","year":"2001","journal-title":"J Neurosci"},{"key":"2026010905594828200_szaf071-B10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/s1071-9091(98)80033-8","article-title":"Human oligodendroglial development: relationship to periventricular leukomalacia","volume":"5","author":"Kinney","year":"1998","journal-title":"Semin Pediatr Neurol"},{"key":"2026010905594828200_szaf071-B11","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1523\/JNEUROSCI.13-04-01441.1993","article-title":"Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention","volume":"13","author":"Oka","year":"1993","journal-title":"J Neurosci"},{"key":"2026010905594828200_szaf071-B12","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJMoa0900854","article-title":"Moderate hypothermia to treat perinatal asphyxial encephalopathy","volume":"361","author":"Azzopardi","year":"2009","journal-title":"N Engl J Med"},{"key":"2026010905594828200_szaf071-B13","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ijdevneu.2011.04.004","article-title":"The biological basis of injury and neuroprotection in the fetal and neonatal brain","volume":"29","author":"Rees","year":"2011","journal-title":"Int J Dev Neurosci"},{"key":"2026010905594828200_szaf071-B14","doi-asserted-by":"publisher","first-page":"764251","DOI":"10.1155\/2015\/764251","article-title":"Protective effects of N-acetyl-L-cysteine in human oligodendrocyte progenitor cells and restoration of motor function in neonatal rats with hypoxic-ischemic encephalopathy","volume":"2015","author":"Park","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"2026010905594828200_szaf071-B15","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/jp.2009.1","article-title":"Ascorbic acid combined with ibuprofen in hypoxic ischemic encephalopathy: a randomized controlled trial","volume":"29","author":"Aly","year":"2009","journal-title":"J Perinatol"},{"key":"2026010905594828200_szaf071-B16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.expneurol.2004.01.011","article-title":"Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model","volume":"189","author":"Tsuji","year":"2004","journal-title":"Exp Neurol"},{"key":"2026010905594828200_szaf071-B17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neulet.2008.12.013","article-title":"Combination of deferoxamine and erythropoietin: therapy for hypoxia-ischemia-induced brain injury in the neonatal rat?","volume":"451","author":"van der Kooij","year":"2009","journal-title":"Neurosci Lett"},{"key":"2026010905594828200_szaf071-B18","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/jnr.22054","article-title":"Stem cell-based cell therapy in neurological diseases: a review","volume":"87","author":"Kim","year":"2009","journal-title":"J Neurosci Res"},{"key":"2026010905594828200_szaf071-B19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1471-2202-10-117","article-title":"Transplantation of human neural stem cells transduced with Olig2 transcription factor improves locomotor recovery and enhances myelination in the white matter of rat spinal cord following contusive injury","volume":"10","author":"Hwang","year":"2009","journal-title":"BMC Neurosci"},{"key":"2026010905594828200_szaf071-B20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3727\/215517913x658936","article-title":"Transplantation of human adipose tissue-derived mesenchymal stem cells restores the neurobehavioral disorders of rats with neonatal hypoxic-ischemic encephalopathy","volume":"5","author":"Park","year":"2013","journal-title":"Cell Med"},{"key":"2026010905594828200_szaf071-B21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles: exosomes, microvesicles, and friends","volume":"200","author":"Raposo","year":"2013","journal-title":"J Cell Biol"},{"key":"2026010905594828200_szaf071-B22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3389\/fcell.2019.00315","article-title":"The art of intercellular wireless communications: exosomes in heart disease and therapy","volume":"7","author":"Patil","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"2026010905594828200_szaf071-B23","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1096\/fj.201700600R","article-title":"Exosomes derived from hypoxia-preconditioned mesenchymal stromal cells ameliorate cognitive decline by rescuing synaptic dysfunction and regulating inflammatory responses in APP\/PS1 mice","volume":"32","author":"Cui","year":"2018","journal-title":"Faseb J"},{"key":"2026010905594828200_szaf071-B24","doi-asserted-by":"publisher","first-page":"9532","DOI":"10.3390\/ijms23179532","article-title":"The neuroprotective effects of exosomes derived from TSG101-overexpressing human neural stem cells in a stroke model","volume":"23","author":"Yoon","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026010905594828200_szaf071-B25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000527514","article-title":"Effect of human amniotic epithelial stem cell transplantation on preterm premature rupture of fetal membrane using the amniotic pore culture technique in vitro","volume":"87","author":"Kang","year":"2022","journal-title":"Gynecol Obstet Invest"},{"key":"2026010905594828200_szaf071-B26","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.expneurol.2011.12.040","article-title":"Human neural stem cells over-expressing choline acetyltransferase restore cognition in rat model of cognitive dysfunction","volume":"234","author":"Park","year":"2012","journal-title":"Exp Neurol"},{"key":"2026010905594828200_szaf071-B27","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3390\/nu10101375","article-title":"The ethanol fraction of white rose petal extract abrogates excitotoxicity-induced neuronal damage in vivo and in vitro through inhibition of oxidative stress and proinflammation","volume":"10","author":"Yon","year":"2018","journal-title":"Nutrients"},{"key":"2026010905594828200_szaf071-B28","doi-asserted-by":"publisher","first-page":"8073","DOI":"10.3390\/ijms24098073","article-title":"Intraocular pressure-lowering and retina-protective effects of exosome-rich conditioned media from human amniotic membrane stem cells in a rat model of glaucoma","volume":"24","author":"Seong","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026010905594828200_szaf071-B29","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.3390\/ijms21124407","article-title":"Transport of extracellular vesicles across the blood-brain barrier: brain pharmacokinetics and effects of inflammation","volume":"21","author":"Banks","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026010905594828200_szaf071-B30","doi-asserted-by":"publisher","first-page":"4412","DOI":"10.1523\/JNEUROSCI.0477-04.2004","article-title":"Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate","volume":"24","author":"Follett","year":"2004","journal-title":"J Neurosci"},{"key":"2026010905594828200_szaf071-B31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5625\/lar.2011.27.2.77","article-title":"Animal models of periventricular leukomalacia","volume":"27","author":"Choi","year":"2011","journal-title":"Lab Anim Res"},{"key":"2026010905594828200_szaf071-B32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5625\/lar.2010.26.4.345","article-title":"Experimental models of cerebral palsy in infant rats","volume":"26","author":"Park","year":"2010","journal-title":"Lab Anim Res"},{"key":"2026010905594828200_szaf071-B33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.31216\/BDL.20230019","article-title":"The effect on differentiation and maturation of oligodendrocyte by age of cerebral palsy modeling using Sprague Dawley rat","volume":"13","author":"Yoon","year":"2023","journal-title":"Brain, Digital, & Learning"},{"key":"2026010905594828200_szaf071-B34","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.2147\/IJN.S291956","article-title":"A comprehensive review on factors influences biogenesis, functions, therapeutic and clinical implications of exosomes","volume":"16","author":"Gurunathan","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"2026010905594828200_szaf071-B35","doi-asserted-by":"publisher","first-page":"116321","DOI":"10.1016\/j.biopha.2024.116321","article-title":"Human amniotic mesenchymal stromal cell-derived exosomes promote neuronal function by inhibiting excessive apoptosis in a hypoxia\/ischemia-induced cerebral palsy model: a preclinical study","volume":"173","author":"Zhou","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"2026010905594828200_szaf071-B36","doi-asserted-by":"publisher","first-page":"911","DOI":"10.17219\/acem\/192773","article-title":"Human umbilical cord mesenchymal stem cell-derived exosomes combined with mouse nerve growth factor can more effectively ameliorate the motor disorder and brain pathological injury in mice with cerebral palsy","volume":"34","author":"Chen","year":"2025","journal-title":"Adv Clin Exp Med"},{"key":"2026010905594828200_szaf071-B37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.4274\/balkanmedj.galenos.2024.2024-6-25","article-title":"Preconditioning of human umbilical cord mesenchymal stem cells with a histone deacetylase inhibitor: valproic acid","volume":"41","author":"Isildar","year":"2024","journal-title":"Balkan Med J"},{"key":"2026010905594828200_szaf071-B38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/jemt.24420","article-title":"Investigation of conditioned medium properties obtained from human umbilical cord mesenchymal stem\/stromal cells preconditioned with dimethyloxalylglycine in a correlation with ultrastructural changes","volume":"87","author":"Olcar","year":"2024","journal-title":"Microsc Res Tech"},{"key":"2026010905594828200_szaf071-B39","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.1016\/j.biomaterials.2014.02.037","article-title":"The effect of systemic PTEN antagonist peptides on axon growth and functional recovery after spinal cord injury","volume":"35","author":"Ohtake","year":"2014","journal-title":"Biomaterials"},{"key":"2026010905594828200_szaf071-B40","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/s0896-6273(00)80469-9","article-title":"Oligodendrocyte population dynamics and the role of PDGF in vivo","volume":"20","author":"Calver","year":"1998","journal-title":"Neuron"},{"key":"2026010905594828200_szaf071-B41","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1242\/dev.010454","article-title":"Sox9 and Sox10 influence survival and migration of oligodendrocyte precursors in the spinal cord by regulating PDGF receptor alpha expression","volume":"135","author":"Finzsch","year":"2008","journal-title":"Development"},{"key":"2026010905594828200_szaf071-B42","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/dneu.22849","article-title":"Using the lineage determinants Olig2 and Sox10 to explore transcriptional regulation of oligodendrocyte development","volume":"81","author":"Sock","year":"2021","journal-title":"Dev Neurobiol"},{"key":"2026010905594828200_szaf071-B43","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/s0360-3016(03)00735-1","article-title":"Changes in oligodendrocytes and myelin gene expression after radiation in the rodent spinal cord","volume":"57","author":"Atkinson","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026010905594828200_szaf071-B44","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.1038\/s41467-024-49524-2","article-title":"Disruption of myelin structure and oligodendrocyte maturation in a macaque model of congenital zika infection","volume":"15","author":"Tisoncik-Go","year":"2024","journal-title":"Nat Commun"},{"key":"2026010905594828200_szaf071-B45","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/cbin.11500","article-title":"Potential role of NGF, BDNF, and their receptors in oligodendrocytes differentiation from neural stem cell: an in vitro study","volume":"45","author":"Langhnoja","year":"2021","journal-title":"Cell Biol Int"},{"key":"2026010905594828200_szaf071-B46","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1006\/mcne.1996.0053","article-title":"Ciliary neurotrophic factor enhances the rate of oligodendrocyte generation","volume":"8","author":"Barres","year":"1996","journal-title":"Mol Cell Neurosci"},{"key":"2026010905594828200_szaf071-B47","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.expneurol.2006.12.013","article-title":"CNTF promotes the survival and differentiation of adult spinal cord-derived oligodendrocyte precursor cells in vitro but fails to promote remyelination in vivo","volume":"204","author":"Talbott","year":"2007","journal-title":"Exp Neurol"},{"key":"2026010905594828200_szaf071-B48","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/glia.23939","article-title":"The impact of trophic and immunomodulatory factors on oligodendrocyte maturation: potential treatments for encephalopathy of prematurity","volume":"69","author":"Vaes","year":"2021","journal-title":"Glia"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/15\/1\/szaf071\/66321297\/szaf071.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/15\/1\/szaf071\/66321297\/szaf071.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T10:59:53Z","timestamp":1767956393000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/doi\/10.1093\/stcltm\/szaf071\/8417863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,9]]}},"URL":"https:\/\/doi.org\/10.1093\/stcltm\/szaf071","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]},"article-number":"szaf071"}}